In the News

Press Releases | In the News

This section and the included news items are presented for informational purposes only. The links provided and the news items themselves do not constitute endorsement by Novan.

DateTitle
03/27/17Exclusive: Novan CEO Talks Strategic Partnerships, 2017 Pipeline, Finance Evaluation
03/23/17The Focus for FDA approval: Former Quintiles Exec Moves to Novan
03/20/17VIDEO: Nitric oxide-releasing Gel Shows Efficacy in Treating Genital Warts
03/05/17Nitric Oxide Gel Shows Promise for Genital Warts
02/28/17HPV and Genital Warts
10/26/16What's Next for Novan After Its IPO?
10/25/16Novan Only Piercing the Skin of Its Potential Says CEO
10/10/16Novan gets new digs in RTP
05/24/16Improved Understanding of Inflammation in Acne Pathophysiology: Leading to New Developments in Treatment
11/30/15Novel Advances in Acne Therapy
11/13/15What You Need to Know About Novan Therapeutics
11/02/15Study Finds Doctors Overuse Antibiotics for Acne Care
10/27/15Durham's Novan Therapeutics Adds Manufacturing Facility for New Drugs
03/30/15Skincare startup bags $50M to get its acne drug into Phase III
03/25/15Exclusive: Glaxo vet Ingram talks about Malin Corp.'s deal with Viamet, Novan
09/12/14How to Attract Smart People, Smart Ideas, and Smart Money
06/17/14High-Tech Small Businesses Receive Tibbetts Awards for Innovative and Outstanding Contributions
05/05/14Novan Wins ‘Buzz of BIO’ Spotlight
04/14/14AAD Winter 2014 Meeting Highlights
02/10/14Novan seeks to unleash power of nitric oxide in ‘tunable’ drugs
12/01/13Industry Report: New Players Emerge as Consolidation Continues
08/26/13Durham Drug Company Novan Awarded $7.8 Million Government Contract
04/12/13Cree co-founder shares startup wisdom
04/12/13Backers with Pedigrees Give Drug Firm Heft